Recent studies identified basic biological principles that are shared by the immune and the nervous system. One of these analogies applies to the orchestration of cellular migration where guidance proteins that serve as a stop signal for axonal migration can also serve as a stop signal for the migration of immune-competent cells. The control of leukocyte migration is of key interest during conditions associated with inflammatory tissue changes such as tissue hypoxia or hypoxic inflammation. Semaphorins are members of these axon guidance molecules. Previously unknown, we report here the expression and induction of semaphorin 7A (SEMA7A) on endothelium through hypoxia-inducible factor 1α during hypoxia. This induction of SEMA7A translates into increased transmigration of polymorphonuclear neutrophil granulocytes across endothelial cells. Extension of these findings demonstrated an attenuated extravasation of polymorphonuclear neutrophil granulocytes in Sema7a-deficient mice from the vasculature during hypoxia. Studies using chimeric animals identified the expression of Sema7A on nonhematopoietic tissue to be the underlying cause of the observed results. Taken together, our findings demonstrate that neuronal guidance proteins do not only serve as a stop signal for leukocyte migration but also can propagate the extravasation of leukocytes from the vascular space. Future antiinflammatory strategies might be based on this finding. endothelia | inflammation R ecent years have identified a close link between hypoxia and inflammation (1). Similar to an acute inflammatory response, hypoxia is marked by increased paracellular fluid exchange and the extravasation of immune-competent cells from the vascular space. Likewise, limited oxygen availability might be the product of the characteristic metabolic changes of inflammation leading to inflammation-associated hypoxia. In addition, proinflammatory cytokines that are released upon stimulation of the immune system might also be part of the hypoxia-enhanced expression of the transcription factor NF-κB (2). Neuronal guidance proteins (NGPs) notably mitigate the course of this process (3-5). For example, cues initially reported to guide neuronal growth and migration, such as netrin-1 or the repulsive guidance molecule (RGM)-A, reduce inflammatory tissue changes (4-6).
Recent studies identified basic biological principles that are shared by the immune and the nervous system. One of these analogies applies to the orchestration of cellular migration where guidance proteins that serve as a stop signal for axonal migration can also serve as a stop signal for the migration of immune-competent cells. The control of leukocyte migration is of key interest during conditions associated with inflammatory tissue changes such as tissue hypoxia or hypoxic inflammation. Semaphorins are members of these axon guidance molecules. Previously unknown, we report here the expression and induction of semaphorin 7A (SEMA7A) on endothelium through hypoxia-inducible factor 1α during hypoxia. This induction of SEMA7A translates into increased transmigration of polymorphonuclear neutrophil granulocytes across endothelial cells. Extension of these findings demonstrated an attenuated extravasation of polymorphonuclear neutrophil granulocytes in Sema7a-deficient mice from the vasculature during hypoxia. Studies using chimeric animals identified the expression of Sema7A on nonhematopoietic tissue to be the underlying cause of the observed results. Taken together, our findings demonstrate that neuronal guidance proteins do not only serve as a stop signal for leukocyte migration but also can propagate the extravasation of leukocytes from the vascular space. Future antiinflammatory strategies might be based on this finding.
endothelia | inflammation R ecent years have identified a close link between hypoxia and inflammation (1) . Similar to an acute inflammatory response, hypoxia is marked by increased paracellular fluid exchange and the extravasation of immune-competent cells from the vascular space. Likewise, limited oxygen availability might be the product of the characteristic metabolic changes of inflammation leading to inflammation-associated hypoxia. In addition, proinflammatory cytokines that are released upon stimulation of the immune system might also be part of the hypoxia-enhanced expression of the transcription factor NF-κB (2) . Neuronal guidance proteins (NGPs) notably mitigate the course of this process (3) (4) (5) . For example, cues initially reported to guide neuronal growth and migration, such as netrin-1 or the repulsive guidance molecule (RGM)-A, reduce inflammatory tissue changes (4) (5) (6) .
A member of these NGPs are the semaphorins, a large family of secreted and cell-surface proteins recently found to modulate neurite extension. A member of this family, Semaphorin 7A (SEMA7A), holds the ability to induce the production of cytokines in macrophages and monocytes, which play a significant role during the effector phase of the inflammatory immune response (7, 8) . Furthermore, SEMA7A also stimulates cytoskeletal reorganization in melanocytes and monocytes, which translates into cell morphology changes that can result in spreading and migration of these types of cells (9) (10) (11) . However, to date, the role and expression of SEMA7A during hypoxia was unknown.
On the basis of these observations, we examined the influence of hypoxia on the regulation of endothelial Semaphorin 7A and its role in the development of the hypoxia-elicited inflammatory response. Our findings identified endothelial SEMA7A as an NGP reported to intensify inflammatory damage by promoting neutrophil trafficking. Moreover, this study shows that SEMA7A is strongly induced by hypoxia challenge in a process regulated by the hypoxia-inducible factor (HIF)-1.
Results

Endothelial SEMA7A Promotes Leukocyte Transmigration During
Hypoxia. On the basis of previous findings showing NGPs regulating neutrophil trafficking during hypoxia (4, 5), we started to investigate whether SEMA7A might hold an important role during hypoxic inflammation and in the preservation of vascular barrier function. For this, we first subjected human microvascular endothelial (HMEC)-1 cells to hypoxia [2% (vol/vol) oxygen] and determined transcriptional expression of Semaphorin 7A. We found a strong and time-dependent induction of endothelial SEMA7A-mRNA and protein during hypoxia ( Fig. 1 A and B; ***P < 0.001 by two-tailed Student's t test). On the basis of such robust accumulation of SEMA7A elicited by hypoxia, and given that hypoxia-induced vascular leakage is associated with the accumulation of inflammatory cells in the peripheral tissues, we sought to define the role of SEMA7A on the transendothelial migration of neutrophils. For this purpose, we first either silenced or forced the overexpression of SEMA7A by transfecting HMEC-1 cells with specific siRNA for SEMA7A (Fig. 1C) or with SEMA7A cDNA on a heterologous viral promoter (CMV) (Fig. 1D) , respectively. Transfected cells on semipermeable inserts were then subjected to transmigration assays. As shown in Fig. 1E , lack of endothelial SEMA7A drastically reduced the migration process (**P < 0.01 by two-tailed Student's t test), whereas the opposite effect was caused after forced overexpression of SEMA7A (*P < 0.05 by two-tailed Student's t test). This result indicated that endothelial SEMA7A affects the transmigration process of PMNs through endothelia during hypoxia. Using antibody techniques, we found that this transmigration was dependent on the plexin C1 receptor (Fig. S1 ).
HIF-1 in SEMA7A Induction by Hypoxia. Next, to gain specific insight into the mechanism of SEMA7A regulation during hypoxia, we used available public databases (12) , and, after analysis of the fulllength cDNA, the transcription start site of human SEMA7A was identified at position −18 relative to the first codon ( Fig. 2A) . Three consensus sequences required to constitute a hypoxiaresponsive element (HRE) (13) were detected in the antisense strand of the SEMA7A promoter. They are located at positions −918 to −914 (DNA consensus motif 5′-CACGT-3′), −722 to −718 (5′-CACGG-3′) and −318 to −314 (5′-CACGA-3′), relative to the transcription start site. We used chromatin immunoprecipitation (ChIP) to determine whether the SEMA7A promoter HRE binds HIF-1α. Chromatin-immunoprecipitation analysis of nuclei derived from HMEC-1 cells showed a prominent band for HIF-1α binding in hypoxic samples but not in normoxic samples (Fig. S2 ). To reveal a functional role of these HREs, we used luciferase reporter constructs containing the putative full-length SEMA7A promoter (SEMA7A FL, from −988 to +28). As shown in Fig. 2B , HMEC-1 cells transiently transfected with this construct showed a 3.0-± 0.6-fold increase in luciferase activity after exposure to hypoxia (2% oxygen for 24 h; ***P < 0.001 by two-tailed Student's t test). Specificity for the HRE(s) responsible for such induction was achieved through site-directed mutations that were designed as following: 5′-CACGT-3′ to 5′-CAACG-3′ (SEMA7A Δ-914), 5′-CACGG-3′ to 5′-CGATG-3′ (SEMA7A Δ-718), and 5′-CACGA-3′ to 5′-GCTGA-3′ (SEMA7A Δ-314). As seen in Fig. 2B , lack of HRE at position −918 to −914 abolished the hypoxia responsiveness of the SEMA7A promoter, suggesting a role for this HIF1α-binding site in the induction of SEMA7A during hypoxia. Further evidence for HIF-1α being responsible for SEMA7A regulation during hypoxia was obtained through studies of gain and loss of HIF-1 function. For these studies, we used endothelial HMEC-1 cells expressing either oxygen-stable HIF-1α (HMEC-ΔODD) via lentiviral transduction (Fig. 2C ) or with persistent RNA (psiRNA) repression of HIF-1α (HMEC-HIF-1α) (Fig. 2D) , respectively (14) . These studies revealed that overexpression of HIF-1α in endothelia is associated with induction of SEMA7A even under normoxic conditions (Fig. 2C ), whereas loss of HIF-1α function resulted in the abolishment of SEMA7A regulation during hypoxia (Fig. 2D) . Thus, these findings give strong evidence of the role that HIF-1α plays on SEMA7A regulation during hypoxia.
Endothelial SEMA7A Is Induced by Ambient Hypoxia in Vivo. Prompted by these results, we extended our study into an in vivo model of hypoxia. Here, we first examined the influence of limited oxygen availability (8% O 2 , 92% N 2 for 4 h) on the expression levels of murine Sema7a. As shown in Fig. 3A , Sema7a-mRNA was significantly induced in lung (3.9-± 0.6-fold; ***P < 0.001 by two-tailed Student's t test), liver (2.1-± 0.3-fold; ***P < 0.001 by two-tailed Student t test), and heart (1.7-± 0.2-fold; **P < 0.01 by two-tailed Student's t test) by hypoxia (VEGF served as positive control). In addition, hypoxia-induced increase of Sema7a protein was subsequently corroborated in lung and liver by Western blot (Fig. 3B ) and by immunohistochemistry ( Fig. 3C ; Figs. S3 and S4). In the latter immunohistochemistry, endothelial location of pulmonary Sema7a was demonstrated by coimmunostaining for the specific endothelial marker von Willebrand's factor (vWF). was evaluated by assessment of myeloperoxidase activity in a number of organs as well as by specific PMN staining in lung ( Fig. 4 A and B) . Consistent with previously published studies, the exposure to normobaric hypoxia significantly increased tissue accumulation of PMNs. This hypoxia-induced influx of PMNs was notably attenuated in lung and heart of Sema7a −/− mice compared with WT controls (Fig. 4 A and B; ### P < 0.001 by one-way ANOVA). These experiments confirm Sema7a as a potent mediator of PMN transmigration during hypoxia in vivo. Reorganization of the cytoskeleton and changes in cell morphology has been associated with the activation of semaphorin 7A receptor Plexin C1 in melanocytes and monocytes (7, 9, 10) . (14) . Comparison of vascular permeability in WT and Sema7a-deficient mice subjected to hypoxic conditions revealed significantly increased vascular leak in all animals, however attenuated in Sema7a −/− mice ( Fig. 4C: ### P < 0.001 for lung and heart and # P < 0.05 for liver by one-way ANOVA).
Nonhematopoietic Sema7a Is Responsible for Aggravation of Lung
Injury During Hypoxia. On the basis of the above findings, we next sought to identify the specific myeloid or tissue origin of Sema7a for the observed results. To this aim, we generated chimeric animals through bone marrow transplantation between WT and Sema7a −/− mice and vice versa, with WT to WT and Sema7a −/− to Sema7a −/− transplanted animals as controls for nonspecific radiation effects. Then chimeric animals were exposed to hypoxia, and the extent of lung injury was evaluated as before. Bone marrow chimeric mice with nonhematopoetic Sema7a knockout showed 
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Full-length and indicated constructs containing mutations in one of the HRE were transfected into HMEC-1 cells and assayed for luciferase activity after exposure to hypoxia for 24 h. Results depict the fold change in relative luminescence in hypoxia relative to normoxic controls. An HRE plasmid containing four tandem HREs is shown as a hypoxia-positive control. Data shown are pooled from n = 6 and are normalized for background vector (empty pGL4.17) and total protein and are presented as mean ± SD, where ***P < 0.001 indicates significance between individual plasmids and empty pGL4.17 plasmid by two-tailed Student's t test. (C) Confluent monolayers of control (HMEC-WT) or oxygen-stable HIF-1α-expressing (HMEC-ΔODD) HMEC-1 cell lines or (D) HMEC-1 with psiRNA repression of HIF-1α (HMEC-HIF1α) or control transfected cells (HMEC-Scr) were exposed to 24 h of hypoxia (2% oxygen). SEMA7A transcript levels were afterward determined by RT-PCR and Western blot. ***P < 0.001 and *P < 0.05 indicate significance between normoxia and hypoxia; ### P < 0.001, ## P < 0.01, and # P < 0.05 indicate differences between different cell types by one-factor ANOVA. Data are representative of at least five independent experiments. In C and D, one representative Western blot of three independent experiments is depicted. (A) Sema7a-mRNA levels were examined in lung, liver, and heart from mice subjected either to normoxia or normobaric hypoxia (8% oxygen) for 4 h. Levels of VEGFmRNA were also assayed as positive control for hypoxia exposure. Data are pooled from two independent experiments with n ≥ 5 mice (***P < 0.001 and **P < 0.01 indicate differences between normoxia and hypoxia by two-tailed Student's t test). (B) Analysis of Sema7a protein in lung and liver from mice after normoxia or hypoxia exposure. Protein samples were pooled (n = 6) before being electrophoresed. (C ) Pulmonary immunohistochemistry for murine semaphorin 7A and von Willebrand's factor during hypoxia. Lung from mice exposed to normobaric hypoxia or normoxia for 4 h were harvested and embedded in paraffin. Sections were stained with specific antibodies against murine Sema7a (green) and the endothelial marker von Willebrand's factor (red). Colocalization of Sema7a with von Willebrand's factor (vWF) is seen as yellow in the Overlay image. DAPI was used for nuclear counterstain (blue) (magnification 200×). One representative picture from four different lung sections is displayed.
(Scale bars, 50 μm.) concentrations were determined in lung, liver, and heart. Data are expressed as mean ± SD. Data from Evan's blue OD/50-mg wet tissue are pooled from six animals per condition (***P < 0.001 indicates differences between normoxia and hypoxia; ### P < 0.001 and # P < 0.05 indicate differences between wild-type and Sema7a −/− organs by one-factor ANOVA). (D) MPO measurement in lung of chimeric animals 4 h after exposure to normoxia or normobaric hypoxia.
Mean values of two independent experiments with n ≥ 5 mice per group ± SD are represented (***P < 0.001 reflects differences between indicated chimeric animals by one-factor ANOVA). (E) Staining of PMNs in histological sections of pulmonary tissue of myeloid-and tissue-specific chimeric mice (magnification 400×; detail 1,000×). A representative picture from three different lung sections is displayed. (F) Evan's blue pulmonary extravasation in chimeric animals 4 h after exposure to normoxia or normobaric hypoxia. Data are expressed as mean ± SD. Data from Evan's blue OD/50-mg wet tissue are pooled from two independent experiments with n ≥ 5 mice per condition (***P < 0.001 reflects differences between indicated chimeric animals by one-factor ANOVA). [Scale bars, 50 μm (400×) and 10 μm (1,000×) .]
reduced infiltration of PMNs compared with the animals designated as being nonhematopoetic WT, as demonstrated by examination of myeloperoxidase (MPO) activity (nonhematopoetic Sema7a −/− 0.096 ± 0.006 and nonhematopoetic WT 0.16 ± 0.02, ***P < 0.001 by one-way ANOVA; Fig. 4D), PMN staining (Fig.  4E) , and extravasation of Evan's blue (nonhematopoetic Sema7a −/− 0.093 ± 0.04 and nonhematopoetic WT 0.209 ± 0.04; ***P < 0.001 by one-way ANOVA; Fig. 4F ). This finding gives evidence that endothelial Sema7a plays an active and important part in regulation of vascular permeability during hypoxia, the extravasation of inflammatory cells, and the accompanied inflammatory changes.
Discussion
Initially found to regulate neurite growth, the role of semaphorins in the immune response has emerged during the recent past years. In the present study, we explored the role of Semaphorin 7A in regulating PMN trafficking during hypoxia-elicited inflammation. Our work reports the presence of hypoxia-inducible SEMA7A on endothelial cells and its potential to promote transendothelial leukocyte migration.
During the past years numerous studies have illustrated the cross talk between the immune and nervous systems (15) . Such bidirectional communication involves cytokine-induced neurological responses (16, 17) , as well as the modulation of the immune response by neurotransmitters and neuronal guidance proteins (4, 5, 18) . Interestingly, whereas in the former case both protective and deteriorative neurologic responses may be triggered by immune-related compounds (15) , in the latter there is a preserved correlation of NGPs serving as a stop signal both for axonal migration and for migration of leukocytes, as demonstrated for netrin-1 and RGM-A (4) (5) (6) 19) . In other words, to date there was only evidence of a protective immune response for NGPs during hypoxia and inflammation. However, our transmigration experiments show that SEMA7A enhances PMN trafficking through the endothelial layer. Furthermore, SEMA7A-deficient mice present a significantly reduced level of PMN infiltration during hypoxia in comparison with the wild-type controls, as well as attenuated levels of the inflammatory marker myeloperoxidase. We therefore reveal here Semaphorin 7A as a member of the guidance protein group reported to increase extravascular migration of immunecompetent cells and therefore to promote a proinflammatory response. Direct implication of this finding is the positioning of SEMA7A as a promising target for the development of strategies against inflammatory disorders.
However, with our findings showing hypoxia-inducible Semaphorin 7A in the vascular endothelium able to regulate leukocyte trafficking, we identify an endothelial mechanism being involved in NGP-regulated PMN transmigration. Semaphorin 7A can act through the activation of two different receptors, Plexin C1 and α1β1-integrin. As regards to the SEMA7A receptor(s) involved in the transmigration process, most of the published works associate α1β1-integrin receptors with immunomodulatory functions (8, 20) , whereas Plexin C1 receptors have been associated with adhesion, dendricity, and changes in the cytoskeleton (7, 9) . In in vitro studies, we were able to demonstrate that SEMA7A facilitates increased transendothelial migration of neutrophils depending on the Plexin C1 receptor, although further studies must be carried out to elucidate this finding in vivo.
The immune response is prone to shifts in the oxygen tension (21) . As such, to adapt to the change in energy supply generated in hypoxic areas or inflamed tissues, HIF-1α induces the immune cells to switch from an aerobic metabolism to glycolysis. Such adaptation significantly affects the activity of these cells, and therefore the associated immune response (21) . Furthermore, HIF-1α also promotes transmigration of vascular immunocompetent cells into the affected tissues (22) . In fact, conditional deletion of HIF-1α in mice results in impaired myeloid cell aggregation, motility, and invasiveness (23) . Considering this, we have demonstrated HIF-1α to be involved in the induction of SEMA7A in the vascular endothelium during hypoxia, which thereby supports the fact that hypoxia induces leukocyte migration from the vasculature.
Together, these findings imply that SEMA7A not only triggers the inflammatory response by activation of monocytes and macrophages at sites of inflammation (8) , but also drives the accumulation of PMNs into these sites, thus further enhancing an immune response. In addition, given that the release of SEMA7A to the medium by cleavage of its GPI anchor has been demonstrated to be essential in some processes (24) , further autocrine activation of transmigrated PMNs by solubilized SEMA7A might be possible (25) . Taken together, endothelial SEMA7A rises as a potential therapeutic target for the treatment of hypoxia-induced inflammatory disorders in the future.
Materials and Methods
Transcriptional Analysis. HMEC-1 cells were grown to confluency and subjected to normoxia or different periods of hypoxia (2% oxygen). Semiquantitative analysis of Semaphorin 7A mRNA was performed using real-time PCR (iCycler; Bio-Rad Laboratories Inc.). For human Semaphorin 7A, the primer set consisted of the sense primer 5′-ACA GGG GCA CTA TCC ACA AG-3′ and the antisense primer 5′-CTC AGC ATC CAG CGA CAT-3′. Human β-actin (sense primer 5′-TGA CGG GGT CAC CCA CAC TGT GCC CAT CTA-3′ and antisense primer 5′-CTA GAA GCA TTT GCG GTG GAC GAT GGA GGG-3′) in identical reactions was used as control for starting template. Transcriptional analysis of murine Semaphorin 7A was performed using the sense primer 5′-CGT GTA TTC GCT TGG TGA CAT-3′ and the antisense primer 5′-GTG GGT ATG GGC TGC TTT TT-3′. Samples were controlled for murine β-actin using the following set of primers: sense 5′-TCA CGC ACG ATT TCC CTC TCA G-3′ and antisense 5′-CTC TCC CTC ACG CCA TCC TG-3′. As control for hypoxia, expression levels of human (sense primer 5′-TTG CCT TGC TCT ACC TC-3′ and antisense primer 5′-AGC TGC GCT GAT AGA CAT CC-3′) and murine (sense primer 5′-CAG CTA TTG CCG TCC GAT TGA GA-3′ and antisense primer 5′-TGC TGG CTT TGG TGA GGT TTG AT-3′) VEGF were also examined by RT-PCR.
Protein Analysis. HMEC-1 or murine tissues were analyzed by Western blot as described previously. Particularly, polyclonal goat and rabbit anti-Semaphorin 7A antibodies (Abcam) as well as a rabbit monoclonal anti-β-actin antibody (Cell Signaling) were used in Western blots for human and murine samples, respectively.
Semaphorin 7A Reporter Assays. Promoter analysis and identification of the transcription start site as well as of potential HIF-1α-binding sites were done using MatInspector by Genomatix, as described previously (6) . Vector pGL4.17-expressing sequence corresponding to full-length Semaphorin 7A promoter-either native (SEMA7A FL, −988 to +29, 1,017 bp) or containing mutations in one of the following potential HIF-1α-binding sites: SEMA7A Δ-914 (bp −914 to −918), SEMA7A Δ-718 (bp −718 to −722), and SEMA7A Δ-314 (bp −314 to −318)-were purchased from GeneArt. New sequences were checked using MatInspector to ensure that no new transcription factor-binding sites were generated. As control for hypoxia, cells were transfected with a pGL4-based HRE plasmid containing four tandem HIF-1 enhancer sequences from the 3′-region of the erythropoietin gene (26) . Transfection of HMEC-1 cells was accomplished using standard conditions of GeneJuice Transfection Reagent (EMD Biosciences, Inc.). Cells were subjected to hypoxia or normoxia for 24 h. Luciferase activity was assessed (Turner Designs) using a luciferase assay kit (Promega). All firefly luciferase activity was normalized with respect to total protein content.
HIF-1α ChIP. The ChIP assay (CHP1; Sigma-Aldrich) was performed according to the manufacturer's instructions. As the ChIP-qualified antibody of interest, we used HIF1α antibody (NB100-134; Novus Biologicals Inc.). For PCR detection of Sema7a, we used the following primers (5′-ggc tca gtc tcg gct gat t-3′ and 5′-ctt tcc aga cgg cga aga t-3′).
Suppression and Forced Overexpression of Semaphorin 7A. HMEC-1 cells were grown either on transwell inserts (Costar) or in 60-mm petri dishes. A set of siRNA directed against human Semaphorin 7A was purchased from Ambion. As control, HMEC-1 cells were transfected in parallel with a scrambled control siRNA (Ambion). On the other hand, overexpression of Semaphorin 7A was achieved by transfection with a SEMA7A-pCMV6 vector (Origene) or control plasmid pCMV6_XL5 (Origene). Both reagents were tested by RT-PCR and Western blot for their efficiency to suppress/enhance Semaphorin 7A
